Eql Pharma AB (7JK)
XDUS 
Summary
7JK Chart
Eql Pharma AB (7JK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Eql Pharma AB ever had a stock split?
Eql Pharma AB Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Axel Schorling CEO | XDUS Exchange | SE0005497732 ISIN |
| Sweden Country | 20 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
EQL Pharma AB (publ), founded in 2006 and headquartered in Lund, Sweden, operates in the pharmaceutical sector, focusing on the development, marketing, and sales of generic medicines across Sweden, Denmark, Norway, Finland, and other European regions. The company strategically positions itself within the pharmaceutical market by targeting both pharmacies and hospitals, ensuring a comprehensive reach in the outpatient and inpatient care sectors. Its core mission revolves around providing cost-effective, generic medical solutions that aim to enhance patient care and accessibility.
Products and Services
- Injection Products for Inpatient Care
These are specialized pharmaceutical products designed for use within hospital settings, catering to the needs of inpatients. EQL Pharma AB extends its product range to include generic injectables, which are crucial for various treatment protocols, ensuring high-quality standards and reliability for acute care scenarios.
- Formulations for Outpatient Care
For patients receiving medical treatment outside of hospital settings, EQL Pharma AB offers a range of generic formulations. These are tailored to meet the everyday health needs of outpatients, focusing on affordability without compromising on efficacy. The outpatient product line encompasses a spectrum of therapeutic areas, aimed at facilitating continued care and management of chronic conditions in a home-based environment.
